Evaluating Safety of Novel LDL Management Mechanism

Deepak Bhatt, MD, MPH, MBA, reviews the efficacy and safety data of inclisiran, highlighting its long-term effects and noting that injection site reactions are among the most prominent adverse reactions associated with this medication.

Related Content:

Optimizing Cardiovascular Health: Advancements in LDL Cholesterol Management through Intensive and Early Treatment StrategiesIcahn School of Medicine at Mount SinaiClinicalCardiologyPeer ExchangeVideo Series

PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering

Educational Video Use in Shared Decision-Making Improves Literacy About Psoriasis

AHA Guidelines and Patient Mortality